ICF

Founded in 2002, ICF was the first Brazilian bioequivalence and bioavailability laboratory to be certified by ANVISA, growing into one of the largest pharmaceutical research centers in Brazil and Latin America. Having conducted more than 700 bioequivalence studies, the company has played a role in the history of generic drugs in Brazil, offering extensive hospital infrastructure, a diversified certified portfolio and 200 bioanalytical methods, including complex methods for hormones and sprays.